Independent register of U.S. FDA drug recalls · updated Oct 14, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

ChloraPrep OneStep

Labeling; Label Mixup; the immediate package is labeled incorrectly as Chloroprep Onestep (Clear), however, the correct label should be Chloroprep with Tint (Hi Lite Orange)

Terminated Labeling / mix-up Becton Dickinson & Company D-0029-2018
Class II · Moderate risk

Aminocaproic Acid

CGMP Deviations: Product manufactured for Industrial Use but was labeled and distributed for Pharmacy Compounding Use.

Terminated Labeling / mix-up Medisca, Inc. NDC 38779-0989-05 D-1174-2017
Class II · Moderate risk

Procrit (epoetin alfa)

Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection.

Terminated Particulate / foreign matter Amgen, Inc. NDC 59676-310-01 D-1173-2017
Class II · Moderate risk

Acarbose Tablets

Labeling: Incorrect or Missing Lot and/or Exp Date: An incorrect expiration date of July 2018 is printed on the product labeling rather than the correct expiration date of July 2017.

Terminated Labeling / mix-up Teva Pharmaceuticals USA NDC 16252-523-01 D-1178-2017
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0160-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0159-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0158-2018
Class II · Moderate risk

Sterile Eyewash

Lack of sterility assurance: leaking containers which could lead to exposure to infectious agents.

Terminated Sterility / contamination Medex Cardio-Pulmonary Inc., d.b.a. Smiths Medical Company D-0157-2018
Class II · Moderate risk

Urin D/S Tablets Methenamine 81.6 mg

Superpotent Drug: Subpotent Drug. FDA analysis found this product to be Out of Specification for assay which could result in either Subpotent and/or Superpotent tablets.

Terminated Wrong potency / content Llorens Pharmaceutical Corp. D-0081-2018

Recalls by year